Cromos Pharma, where the patients are

Drug Sponsors

Almirall to acquire Aqua Pharmaceuticals

Wednesday, December 18, 2013 01:36 PM

Almirall, an international pharmaceutical company based in Spain, has acquired Aqua Pharmaceuticals, a privately-held, U.S.-based prescription dermatology company with a portfolio of prescription brands in acne, steroid-responsive dermatoses, seborrheic dermatitis, actinic keratosis and atopic dermatitis.

More... »

CRF Health eCOA webinar series

Valeant Pharmaceuticals to acquire Solta Medical

Monday, December 16, 2013 02:19 PM

Valeant Pharmaceuticals International will acquire all outstanding common stock of Solta Medical for $2.92 per share in cash, for a transaction value of approximately $250 million. The transaction is expected to close in the first quarter of 2014.

More... »


Vivus, Sanofi ink agreement

Friday, December 13, 2013 01:57 PM

Biopharmaceutical company Vivus has entered into a license and commercialization agreement with Sanofi to commercialize avanafil on an exclusive basis in Africa, the Middle East, Turkey and the Commonwealth of Independent States (CIS) including Russia. Sanofi will be responsible for obtaining regulatory approval in its territories. Sanofi intends to market avanafil under the trade name Spedra or Stendra.

More... »

Johnson & Johnson Innovation establishes network of partnering offices

Monday, December 9, 2013 12:29 PM

Johnson & Johnson Innovation, London, has formed a network of partnering offices across U.K. life science clusters. The offices function as extensions of its London Innovation Center, to work with academics and entrepreneurs throughout the U.K. to identify early stage innovation and support the translation of research into new products for patients.

More... »

AstraZeneca donates Brixham Environmental Laboratory to Plymouth University

Monday, December 9, 2013 12:25 PM

AstraZeneca will donate its Environmental Laboratory in Brixham to Plymouth University to ensure the lab continues to serve scientific and research purposes.

More... »

NIHR Clinical Research Network improves non-commercial study inclusion times

Monday, December 9, 2013 12:22 PM

The National Institute for Health Research (NIHR) Clinical Research Network has decreased the time it takes for studies funded by non-commercial organizations, such as charitable organizations and academic institutions, to be included in the NIHR Portfolio of research.

More... »

The Medicines Company acquires Rempex Pharmaceuticals

Friday, December 6, 2013 01:04 PM

The Medicines Company has acquired Rempex Pharmaceuticals, a company with multiple potential new therapies focused on multi-drug resistant gram-negative bacteria.

More... »

Sarah Cannon Research Institute acquires Clinical Development Group

Friday, December 6, 2013 12:59 PM

Sarah Cannon Research Institute (SCRI), a global strategic research organization, has acquired Clinical Development Group (CDG), a clinical trial consulting firm based in New Haven, Conn.

More... »

Almirall reorganizes in Europe, cuts 250 positions

Friday, December 6, 2013 12:57 PM

Pharmaceutical company Almirall has reorganized in Europe to optimize its portfolio potential. Pharmaceutical markets in Europe, particularly in Spain, have been affected in recent years by economically driven decisions made by various countries’ health authorities that have negatively affected the growth of those markets and the introduction and uptake of new products. 

More... »

Fred Hutchinson, Memorial Sloan-Kettering team up to launch Juno Therapeutics

Thursday, December 5, 2013 10:49 AM

The Fred Hutchinson Cancer Research Center (Fred Hutch) and Memorial Sloan-Kettering Cancer Center (MSKCC), along with pediatric partner Seattle Children’s Research Institute, have joined forces to launch Juno Therapeutics, a new biotechnology company focused on bringing forward novel immunotherapies for cancer.

More... »

CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

April 14

Proposal calls for back-to-back trials to measure efficacy and effectiveness prior to FDA approval

Study: Minority populations under-represented in cancer trials, but have higher rates of incidence

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

Make way for mobile health in clinical trials
Despite patient retention, data quality benefits, regulatory hurdles persist

Global clinical trial laboratories decentralize
Regional labs reducing complexity, delivering cost and time savings

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Strategic alliances hit bumps in the road
Mixed relationship performance driving new approaches

Tapping community hospitals for clinical trial volunteers
New study finds high potential but infrastructure, resources are lacking

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs